Data / Form D filings / SERAPH BIOSCIENCES, INC.
SERAPH BIOSCIENCES, INC.: Form D filings
SERAPH BIOSCIENCES, INC., a biotechnology company in Detroit, MI, filed 4 Form D notices with the SEC between 2017 and 2021. The latest, on August 23, 2021, reports $7 million sold of a $7.2 million offering to 29 investors.
Find out what SERAPH BIOSCIENCES, INC. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1001 WOODWARD AVENUE, SUITE 500, Detroit, MI, 48226
- Phone
- (313) 759-8009
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2016
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1697736
The full lists. Form D filings in Michigan: 506 rows, $25.30, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 23, 2021 | Amendment | $7,200,000 | $7,022,000 | $178,000 | 29 | Dec 21, 2018 | sec.gov |
| Jun 24, 2020 | New notice | $2,500,000 | $1,912,884 | $587,116 | 18 | Jun 15, 2020 | sec.gov |
| Jan 7, 2019 | New notice | $4,200,000 | $1,526,988 | $2,673,012 | 15 | Dec 21, 2018 | sec.gov |
| Feb 15, 2017 | New notice | $5,000,000 | $1,500,000 | $3,500,000 | 1 | Feb 3, 2017 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Gary Loveman | Director | |
| Ahmad Nadeem Ishaque | Director | |
| Charles Shanley | Director | |
| Scott Nadeem Merz | Director | |
| James Nadeem Shanley | Executive Officer | |
| Michael Shields | Director | |
| Richard Nadeem Creager | Director | |
| Braden Nadeem Robison | Executive Officer |
Other biotechnology companies in Michigan that filed recently
- Dvant Pharma, Inc. $1.2 million · Oct 13, 2026
- iReprogram, Inc offering · Aug 13, 2026
Every Form D from the week of Aug 23, 2021 · All recent filings in Michigan · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what SERAPH BIOSCIENCES, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.